U.S. stocks fell Friday after weak job data raised concerns about economic slowdown

Stocks plunged on Friday as new job numbers overwhelmed and underwhelmed Wall Street at the same time.

The labor report triggered a sharp reversal on Wall Street, with expectations now split between a small cut and a more aggressive move when the Fed meets later this month.

The S&P 500 dropped 0.32% to 6,481.50, while the Nasdaq Composite inched down 0.03% to 21,700.39, and the Dow Jones Industrial Average lost 220.43 points, roughly 0.48%, to close at 45,400.86. All three had touched intraday highs earlier, with the S&P 500 up 0.5%, the Nasdaq up 0.8%, and the Dow climbing 0.3% before the labor data crushed the rally.

Only 22,000 new jobs were created in August, far short of the 75,000 that analysts had predicted. While the unemployment rate edged up to 4.3%, as expected, the overall figures were weak enough to boost bets that the Fed will cut rates at its upcoming meeting. Traders are now split between a quarter-point and half-point rate cut, with both on the table, according to the CME FedWatch tool.

Broadcom reveals AI chip order and jumps 9%

Meanwhile, Broadcom gave tech traders something to chew on. The chipmaker’s stock surged 9.4% on Friday after Hock Tan, the company’s CEO, revealed during an earnings call that a $10 billion order had been placed by a new customer for custom AI chips known as XPUs. The order, Tan said, “came from one of these prospects who released production orders to Broadcom,” adding that the company had now recognized them as “a qualified customer for XPUs.”

The deal boosted Broadcom’s forecast for AI-related revenue next year. Though Tan did not name the buyer, analysts at Mizuho, Cantor Fitzgerald, and KeyBanc all pointed to OpenAI. The Financial Times also reported Thursday that Broadcom and OpenAI had co-designed a chip expected to hit the market in 2026.

In a client note Thursday night, Cantor’s analysts wrote: “During the call, the company surprised us by noting that it had secured a $10B order from a fourth XPU customer (we believe this is OpenAI), adding significant upside to the company’s three current XPU customers (Google, Meta, and ByteDance). Shipments are expected to commence in 2026.”

Tech sees billion-dollar deals and robot contracts

Away from the macro mess, tech stories still moved the market. On Thursday night, analysts at Cantor Fitzgerald said one chip company had landed a $10 billion order from a new XPU client. The analysts believe that buyer is OpenAI, which joins existing clients Google, Meta, and ByteDance.

“During the call, the company surprised us by noting that it had secured a $10B order from a fourth XPU customer (we believe this is OpenAI), adding significant upside to the company’s three current XPU customers,” the note read. Shipments from that deal are set to begin in 2026.

Meanwhile, over in China, humanoid robots just broke a sales record. Robotics manufacturer UBTech announced it secured a contract worth 250 million yuan ($35 million) for its Walker S2 robots. That’s now the largest single order for humanoid machines ever recorded. The purchase cements China’s position in the fast-growing robot space.

Elon Musk joined the robot conversation on Tuesday. The Tesla CEO claimed that his Optimus robots could eventually account for around 80% of his company’s total value. While he didn’t provide a timeline or details, that number raised eyebrows. It also spotlighted the growing commercial interest in machines powered by artificial intelligence.

JPMorgan added their take a day later. In a note on Thursday, analysts at the bank pointed to a widening path for robot adoption. “The accelerating pace of commercialization, large-scale contract wins and ongoing supply chain ramp-up point to expanding market opportunities for leading players,” they said.

And they didn’t stop there. JPMorgan believes Chinese companies will come out ahead in the humanoid race, especially with their focus on faster rollout and lower prices.

Earlier this year, CNBC reported that Chinese robotics firms were already ahead of U.S. rivals in getting humanoids out the door. Their edge wasn’t just speed, they were also offering more competitive pricing.

These robots, designed to look and move like humans, are being pitched for use in factories and hospitals. The commercial push is no longer theoretical. Real money is flowing, and contracts are being signed.

Join Bybit now and claim a $50 bonus in minutes